Wealth Quarterback’s CONMED CNMD Stock Holding History

Wealth Quarterback’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4K	Buy	26 +1	+4%	+$131	﹤0.01%	611
2021 Q2	$4K	Buy	+25	New	+$3.42K	﹤0.01%	631

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Wealth Quarterback's CNMD Position: Q3 2021 in Review

Wealth Quarterback increased its CONMED (CNMD) stake by 4% in Q3 2021, buying an estimated $131 and bringing the position to 26 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #611.

Wealth Quarterback first reported a position in CNMD in Q2 2021 and has held it in 2 quarters since. 262 funds tracked by Wall St. Rank hold CNMD as of Q3 2021.

Wealth Quarterback held 26 shares of CONMED worth $4K as of Q3 2021.
Wealth Quarterback bought 1 CONMED share in Q3 2021, an estimated $131.
CONMED made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #611 holding.
Wealth Quarterback first reported a position in CONMED in Q2 2021 and has held it in 2 quarters since.
262 funds tracked by Wall St. Rank held CONMED as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.